*Naotaka Izuo1, Daiki Ikejima1, Kakeru Chino1, Takashi Asano1, Tomoharu Kuboyama2, Chihiro Tohda3, Shin-Ichi Muramatsu4,5, Atsumi Nitta1
(1. Department of Pharmaceutical and Neuropharmacological Therapy, Faculty of Pharmaceutical Sciences, Graduate School of Medical and Pharmaceutical Sciences, University of Toyama, 2. Laboratory of Pharmacognosy, Daiichi University of Pharmacy, 3. Section of Neuromedical Science, Institute of Natural Medicine, University of Toyama, 4. Division of Neurological Gene Therapy, Open Innovation Center, Jichi Medical University, 5. Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo)
Keywords:Shati/Nat8l, Alzheimer's disease, Cognitive dysfunction
Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.